October 2021 Review

It's been a hectic month in the meatverse

2 of our kids have had coronavirus at the end of October.

They are fine - largely fevers, muscle aches and some emotional liability - it’s pretty much settled now, but it’s been disruptive to our usual pattern.

Our C19 vaccine seems to have worked well. Despite receiving a faceful of coronavirus for about a week, my wife and I are well (at least for now).

I am way behind my work admin. There won't be a formal portfolio update this month - I am simply out of time.

Portfolio changes

Buys

$SEMR - average ~ $23

Small add to $ESTC

Tracking position in $DCBO

Sells

Trimmed $TDOC (oversized vs conviction). Will take another look after their investor day in November.

Adventures in the Financial Metaverse @adventuresinfi

@BornInvestor I think there is a decent probability that $TDOC does fine long term. I feel my position is incorrectly sized with respect to my conviction though

Some interesting points from Richard as always on $TDOC…

Richard Chu @richard_chu97

One of the main reasons I invested in $TDOC was the cross-sell opportunity and they guided for just 25% to 35% YoY $LVGO sales growth next year after 2021 adds already came in below expectations. Remember LVGO management projected 60% growth in their merger filing last year...

Trimmed $API and despite it's potential role as a metaverse beneficiary… it's likely on its way out (underperformance, other ideas with less drama….Feel like I really fumbled this one by trying to be cute about taxes)

Portfolio breakdown

Sorry for the brevity.

Have a great November!

Watchlist

$AMPL, $DLO, $MQ

Curious about: $TWST, $DNA